Vitamins & Minerals in Therapeutics

Vitamins and minerals appear in NEET PG not as "nutrition" facts but as therapeutic tools — pyridoxine to prevent isoniazid neuropathy, vitamin K to reverse warfarin, B12/folate to treat megaloblastic anaemia, and iron in its many forms. This note focuses on the pharmacological angle: drug of choice, route, antidotal use, and the deficiency/toxicity that examiners love to contrast.

Why this is tested as pharmacology, not just biochemistry

The reliable NEET PG trap is to give a clinical scenario where a vitamin is used as a drug (e.g. a TB patient on isoniazid, a warfarin overdose, a pregnant woman planning conception) and ask the single best agent, route, or dose. Memorise the therapeutic use separately from the classic deficiency disease — they are frequently juxtaposed in the same question.

High-yield: A vitamin can be (1) a replacement for deficiency, (2) an antidote, or (3) a pharmacological agent used in non-deficient patients (e.g. niacin for dyslipidaemia, vitamin A retinoids for acne). Know which category each question is testing.

Classification of vitamins

Type	Vitamins	Storage	Toxicity risk	Deficiency onset
Fat-soluble	A, D, E, K	Stored in liver/fat	High (accumulate)	Slow (months)
Water-soluble	B-complex, C	Minimal storage (except B12)	Low (excreted)	Fast (weeks)

High-yield: B12 (cyanocobalamin) is the exception among water-soluble vitamins — it is stored in the liver for 3–5 years, so dietary deficiency (strict vegan) takes years to manifest, whereas pernicious anaemia (loss of intrinsic factor) manifests once stores deplete.

Pyridoxine (Vitamin B6) — the antidote vitamin

Pyridoxine is one of the most tested B-vitamins because of its drug-interaction and antidotal roles.

Therapeutic uses (memorise as a list):

1. Isoniazid (INH)-induced peripheral neuropathy — INH increases pyridoxine excretion and inhibits its activation; co-administer 10–25 mg/day prophylactically, treat established neuropathy with higher doses.
2. INH overdose / poisoning — pyridoxine is the specific antidote for INH-induced refractory seizures (gram-for-gram, ~1 g pyridoxine per gram of INH ingested).
3. Sideroblastic anaemia — particularly the hereditary/pyridoxine-responsive form and isoniazid-induced sideroblastic anaemia.
4. Hydralazine, cycloserine, penicillamine — these also cause pyridoxine deficiency/neuropathy.
5. Homocystinuria (B6-responsive type), gyrate atrophy, drug-induced (oral contraceptive) deficiency.
6. Hyperemesis gravidarum / morning sickness — doxylamine + pyridoxine is the classic first-line combination.

High-yield: INH neuropathy is most common in slow acetylators, malnourished, diabetic, alcoholic, pregnant, and uraemic patients. The mechanism is pyridoxine depletion → impaired GABA synthesis (hence seizures) and demyelination.

High-yield: Pyridoxine reduces the efficacy of levodopa (when given without carbidopa) by enhancing peripheral dopa-decarboxylase activity. With carbidopa, this interaction is blocked.

Flow — TB patient develops tingling feet: Patient on INH → burning/paraesthesia in feet (peripheral neuropathy) → cause = pyridoxine deficiency → give pyridoxine (do not stop INH unless severe) → prevent recurrence with prophylactic B6.

Cyanocobalamin (Vitamin B12) and folic acid — megaloblastic anaemia

Both produce megaloblastic (macrocytic) anaemia because both are required for DNA synthesis. Distinguishing them is a perennial question because giving folate alone to a B12-deficient patient corrects the anaemia but precipitates/worsens neurological damage (subacute combined degeneration).

Feature	Vitamin B12 deficiency	Folate deficiency
Body stores	3–5 years	3–4 months
Neurological signs (SACD)	Present (dorsal column, lateral column)	Absent
Methylmalonic acid	Raised	Normal
Homocysteine	Raised	Raised
Common cause	Pernicious anaemia, ileal resection, vegan, fish tapeworm, metformin, PPI	Pregnancy, alcoholism, phenytoin, methotrexate, malabsorption
Schilling test	Abnormal (historical)	Normal

High-yield: Methylmalonic acid is the single best test to distinguish B12 from folate deficiency — it is raised in B12 deficiency only. Homocysteine is raised in both, so it cannot distinguish them.

High-yield: Always rule out / treat B12 deficiency before giving folic acid in megaloblastic anaemia. Folate masks the haematological picture while neurological disease (subacute combined degeneration of the cord) progresses irreversibly.

Hydroxocobalamin is preferred over cyanocobalamin for parenteral therapy because it is more protein-bound and longer-acting. Hydroxocobalamin is also the antidote for cyanide poisoning (binds CN to form cyanocobalamin).

Folic acid in neural tube defect (NTD) prevention:

• Low-risk woman: 400 micrograms/day periconceptionally (at least 1 month before conception through first trimester).
• High-risk (previous NTD child, on antiepileptics, diabetes): 4–5 mg/day.

High-yield: Folate must be started before conception because the neural tube closes by day 28 — by the time pregnancy is confirmed, the protective window has closed.

High-yield: Folinic acid (leucovorin / citrovorum factor) — not folic acid — is used to "rescue" normal cells after high-dose methotrexate and to treat methotrexate toxicity, because methotrexate blocks dihydrofolate reductase and folic acid cannot be activated. Folinic acid bypasses this block.

Mnemonic for megaloblastic causes ("MEGABLAST") — Methotrexate/Metformin, Ethanol, Glutethimide, Anticonvulsants (phenytoin), B12 deficiency, Lack of folate (pregnancy), Antifolates, Sulfasalazine/Sulfa-Trimethoprim, Trimethoprim.

Vitamin K — coagulation and warfarin reversal

Vitamin K (phytonadione/phylloquinone = K1; menaquinone = K2 from gut bacteria) is the cofactor for gamma-carboxylation of factors II, VII, IX, X and proteins C & S.

Therapeutic uses:

1. Warfarin reversal (warfarin inhibits vitamin K epoxide reductase, VKORC1).
2. Haemorrhagic disease of the newborn — single IM dose of vitamin K1 at birth (newborns are deficient: sterile gut, low placental transfer, low breast-milk content).
3. Obstructive jaundice / malabsorption / long-term antibiotics causing deficiency.
4. Vitamin K1 is the antidote for superwarfarin (long-acting rodenticide) poisoning — often needs prolonged high-dose oral therapy.

High-yield: Vitamin K1 (phytonadione) is the preparation of choice for reversing warfarin — K3 (menadione) is obsolete and causes haemolysis and kernicterus in neonates (G6PD).

Flow — choosing warfarin-reversal strategy by urgency:

Situation	Reversal agent
High INR, no bleeding	Hold warfarin ± low-dose oral vitamin K1
Minor bleeding	Vitamin K1 (oral/slow IV)
Major / life-threatening bleed	4-factor PCC (prothrombin complex concentrate) + IV vitamin K1; FFP if PCC unavailable

High-yield: Vitamin K alone takes 6–12 hours to act (needs new factor synthesis). For immediate reversal in life-threatening bleeding, give PCC or FFP for the factors plus vitamin K to sustain reversal. IV vitamin K can rarely cause anaphylaxis, so it is given slowly/diluted.

High-yield: Warfarin's early effect on PT/INR is dominated by factor VII (shortest half-life ~6 h); the early procoagulant risk is from protein C depletion → warfarin-induced skin necrosis, prevented by heparin bridging.

Iron — oral versus parenteral

Iron deficiency anaemia (microcytic hypochromic) is treated by replacing the deficit plus replenishing stores (~1000 mg total).

Oral iron — first line. Ferrous salts are best absorbed (Fe2+ > Fe3+).

Oral salt	Elemental iron content
Ferrous sulfate (325 mg)	~65 mg (20%)
Ferrous fumarate (200 mg)	~65 mg (33%) — highest %
Ferrous gluconate (300 mg)	~36 mg (12%)

High-yield: Ferrous sulfate is the oral iron of choice — cheapest, effective. Take on an empty stomach with vitamin C (ascorbate) to enhance absorption; tea, antacids, calcium, phytates, and PPIs reduce it.

Response to oral iron (sequence to memorise): Reticulocytosis (day 5–10, peaks ~day 7–10) → rise in haemoglobin (~1 g/dL per 2–3 weeks) → continue 3–6 months after Hb normalises to replenish stores.

High-yield: The earliest sign of response to iron therapy is reticulocytosis, beginning by day 5–7. The earliest symptomatic improvement is a sense of wellbeing, even before Hb rises.

Parenteral iron — indications:

1. Intolerance/non-compliance with oral iron.
2. Malabsorption (e.g. coeliac, post-bariatric, IBD where oral worsens disease).
3. Continuing blood loss exceeding oral replacement.
4. Chronic kidney disease on erythropoietin / dialysis.
5. Need to rapidly replenish (late pregnancy, pre-operative).

Parenteral preparations: iron sucrose, ferric carboxymaltose (FCM — large dose in single sitting), iron dextran (highest anaphylaxis risk — test dose required), ferumoxytol.

High-yield: Parenteral iron does NOT produce a faster haemoglobin response than well-absorbed oral iron — it only guarantees delivery. It is given for delivery/compliance problems, not for speed. The Z-track technique for IM iron dextran prevents skin staining.

High-yield: Total dose = body weight (kg) × (target Hb − actual Hb) × 2.21 + 1000 mg (Ganzoni formula) is the classic calculation for iron stores replacement.

Iron poisoning (acute) — pharmacology favourite

Children ingesting adult iron tablets is a classic toxicology MCQ.

Five clinical stages: GI (haemorrhagic gastroenteritis 0.5–6 h) → latent/quiescent (6–24 h) → metabolic acidosis & shock (6–72 h) → hepatic necrosis (12–96 h) → late GI scarring/strictures (weeks).

High-yield: Desferrioxamine (deferoxamine) is the antidote for acute iron poisoning — it chelates free iron, producing a characteristic "vin rosé" (pink/orange) urine (ferrioxamine). Oral deferasirox/deferiprone are used for chronic iron overload (thalassaemia).

Other therapeutically used vitamins (quick block)

• Vitamin A (retinoids): isotretinoin (cystic acne), acitretin (psoriasis), all-trans retinoic acid/ATRA = tretinoin for acute promyelocytic leukaemia (APML, t(15;17)). All retinoids are teratogenic — contraception mandatory.
• Vitamin D: calcitriol/alfacalcidol for renal osteodystrophy and hypoparathyroidism; cholecalciferol for deficiency and osteoporosis adjunct.
• Niacin (B3): highest-efficacy drug for raising HDL; lowers LDL/TG. Side effect = prostaglandin-mediated flushing, prevented by aspirin pre-dose; can cause hyperglycaemia, hyperuricaemia, hepatotoxicity.
• Vitamin C: scurvy treatment; enhances iron absorption; used in methaemoglobinaemia (adjunct).
• Vitamin E: antioxidant; high doses increase bleeding risk (potentiates warfarin).
• Thiamine (B1): Wernicke's encephalopathy — always give thiamine before glucose in alcoholics to avoid precipitating Wernicke's. DOC for wet/dry beriberi.

High-yield: In a malnourished alcoholic brought with altered sensorium, give IV thiamine first; a glucose bolus before thiamine can precipitate acute Wernicke's encephalopathy.

Key minerals as therapeutics (quick block)

• Magnesium sulfate: DOC for eclampsia/pre-eclampsia seizure prophylaxis and torsades de pointes. Antidote for Mg toxicity = IV calcium gluconate (monitor reflexes, RR, urine output).
• Calcium gluconate (IV): first drug in hyperkalaemia with ECG changes (stabilises myocardium) and in symptomatic hypocalcaemia, magnesium toxicity, and calcium-channel-blocker overdose.
• Zinc: adjunct in acute diarrhoea in children (WHO — reduces duration/severity); Wilson's disease (blocks copper absorption); acrodermatitis enteropathica.
• Iodine (Lugol's): thyroid storm and pre-thyroidectomy (Wolff–Chaikoff / Plummer effect) — give after antithyroid drug.

Complications / toxicities to remember

Agent	Toxicity
Vitamin A (excess)	Pseudotumour cerebri, hepatotoxicity, teratogenicity, bone pain
Vitamin D (excess)	Hypercalcaemia, nephrocalcinosis
Pyridoxine (chronic high dose)	Sensory peripheral neuropathy (paradoxical)
Niacin	Flushing, hepatotoxicity, hyperglycaemia, gout
Menadione (K3)	Haemolysis, kernicterus in neonates
Oral iron	GI upset, black stools, constipation
Parenteral iron dextran	Anaphylaxis

High-yield: Both deficiency and excess of pyridoxine cause peripheral neuropathy — deficiency is mixed sensorimotor, while chronic megadose B6 causes a pure sensory neuropathy. A frequent twist in MCQs.

Key differentials / distinctions

• Microcytic anaemia: iron deficiency vs thalassaemia vs sideroblastic vs anaemia of chronic disease — only iron deficiency reliably responds to iron; sideroblastic may respond to pyridoxine.
• Macrocytic anaemia: B12 vs folate (use MMA), vs non-megaloblastic (alcohol, hypothyroidism, liver disease, reticulocytosis).
• Bleeding with raised PT: vitamin K deficiency vs warfarin vs liver disease (factor VII falls first in all; liver disease also lowers factor V, which is not vitamin-K-dependent — helps distinguish).

Recently asked / exam angle

• "TB patient on INH develops burning feet — deficiency of which vitamin?" → Pyridoxine (B6).
• "Best test to differentiate B12 from folate deficiency?" → Methylmalonic acid.
• "Antidote for warfarin overdose / preparation of choice?" → Vitamin K1 (phytonadione); PCC/FFP if life-threatening bleed.
• "Earliest indicator of response to iron therapy?" → Reticulocytosis (day 5–10).
• "Antidote for acute iron poisoning?" → Desferrioxamine (vin rosé urine).
• "Folic acid dose for NTD prevention in low-risk vs high-risk?" → 400 micrograms vs 4–5 mg.
• "Why not give folate alone in B12 deficiency?" → Precipitates subacute combined degeneration.
• "Drug for cyanide poisoning that is a B12 analogue?" → Hydroxocobalamin.
• "Highest elemental iron percentage among oral salts?" → Ferrous fumarate.
• "Rescue after high-dose methotrexate?" → Folinic acid (leucovorin).
• "Give before glucose in alcoholic with altered sensorium?" → Thiamine.

Rapid revision

1. Pyridoxine prevents/treats INH neuropathy, INH-seizure antidote, and pyridoxine-responsive sideroblastic anaemia.
2. INH neuropathy is commonest in slow acetylators and the malnourished.
3. B12 stores last 3–5 years; folate stores 3–4 months.
4. Methylmalonic acid ↑ in B12 deficiency only; homocysteine ↑ in both.
5. Never give folate alone in B12 deficiency — risk of SACD.
6. Folate 400 µg (low risk) / 4–5 mg (high risk) periconceptionally; neural tube closes by day 28.
7. Folinic acid (leucovorin) rescues methotrexate toxicity, not folic acid.
8. Vitamin K1 (phytonadione) is the warfarin antidote; add PCC/FFP for major bleeds; K acts only after 6–12 h.
9. Menadione (K3) causes neonatal haemolysis/kernicterus — avoided.
10. Ferrous sulfate is oral iron of choice; reticulocytosis is earliest response (~day 7).
11. Desferrioxamine treats acute iron poisoning → vin rosé urine; deferasirox/deferiprone for chronic overload.
12. Hydroxocobalamin = cyanide antidote; thiamine before glucose in alcoholics; MgSO4 is DOC for eclampsia (antidote = IV calcium gluconate).